ShortageWatch RxUS drug shortage tracker, built on FDA data

← All shortages

Decitabine Injection shortage

To Be Discontinued  2 presentations · 1 manufacturers · first FDA posting 2026-02-20 · last update 2026-02-20

Manufacturers: Ingenus Pharmaceuticals LLC

Stated reasons (per FDA): Not stated

📬 Get weekly shortage updates by email

Presentations

PresentationManufacturerStatusReasonNotes (FDA)Dates
Decitabine, Injection, 50 mg (NDC 50742-430-01)Ingenus Pharmaceuticals LLCTo Be Discontinued
 —Discontinuation of the manufacture of the drugPosted 02/20/2026
Updated 02/20/2026
Discontinued 02/20/2026
Decitabine, Injection, 50 mg (NDC 68001-573-41)Ingenus Pharmaceuticals LLCTo Be Discontinued
 —Labeler: BluePoint Laboratories; Discontinuation of the manufacture of the drugPosted 02/20/2026
Updated 02/20/2026
Discontinued 02/20/2026

Source: FDA Drug Shortages Database · raw openFDA records

Get the weekly shortage roundup: a free email of FDA shortage changes (open form)